The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The India animal health market was valued at INR 67.83 Billion in 2021.
We expect the India animal health market to exhibit a CAGR of 9.52% during 2022-2027.
The rising incidences of numerous zoonotic diseases, along with the increasing R&D activities in the
veterinary pharmaceutical industry, are currently driving the India animal health market.
The sudden outbreak of the COVID-19 pandemic has led to an increased attention towards animal
health to monitor the symptoms of the coronavirus infection on animals and conduct necessary clinical
Based on the animal type, the India animal health market has been segmented into commercial and
companion. Currently, commercial animals exhibit a clear dominance in the market.
Based on the product type, the India animal health market can be divided into anti-bacterial/antibiotic,
anti-chronic respiratory, anticoccidials, dewormers/antihelmintics, disinfectants, enzymes, fly-
binder/control, growth promoters, gut health (also includes probiotics, prebiotics), liver tonics,
nutritional supplements, toxin binders / immunomodulators / mold inhibitors, vaccines, vitamins/
minerals/ amino acids, and diagnostics. Among these, vaccines currently hold the majority of the total
Based on the distribution channel, the India animal health market can be divided into veterinary
hospitals, veterinary clinics, pharmacies and drug stores, and others. Currently, pharmacies and drug
stores represent the largest market share.
On a regional level, the market has been classified into Uttar Pradesh, Rajasthan, Madhya Pradesh,
Bihar, Andhra Pradesh, Gujarat, and others, where Uttar Pradesh currently dominates the India animal
Some of the major players in the India animal health market include Bayer CropScience Limited,
Boehringer Ingelheim Animal Health, Cargill India Pvt. Ltd., Merck, Ceva Sante Animale, Elanco India
Private Limited, and Virbac Animal Health India Pvt Ltd.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at